Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded site revision tag v3.4.2 and removed the prior funding/status notice (v3.4.1); these are maintenance updates to the site interface and do not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedNotice added about a lapse in government funding and NIH operating status with links to cc.nih.gov and opm.gov. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedA glossary toggle was added; metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision is shown as v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedA minor revision update from v3.3.3 to v3.3.4 is shown, with no substantive changes to the page content.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded location listings for multiple regions (Arkansas, California, Michigan, Missouri, Ontario, Hong Kong, FC, MI, PN, Catalonia) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure link and related location sections.SummaryDifference0.9%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details or user-facing content appear to be changed.SummaryDifference0.0%

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.